Abbott Pulls Meridia Weight Loss Drug on Fatal Heart Attack Concerns | All247News

Links shared publicly online about this topic.

811
total visits

Abbott Pulls Meridia Weight Loss Drug on Fatal Heart Attack Concerns | All247News

Abbott Laboratories (NYSE: ABT) announced Friday that it is pulling its weight loss drug Meridia (sibutramine) from the U.S. market. The company's decision is in line with a request from the Food and Drug Administration (FDA) which cited studies linking the drug with increased risks of heart disease.

View full resource at all247news.com

Tags: Heart, Heart Disease, Heart Attack, Thrombotic Event, Weight Loss, Drug, Abbott Laboratories